相似文献
1
Notch and disease: a growing field.
Semin Cell Dev Biol. 2012 Jun;23(4):473-80. doi: 10.1016/j.semcdb.2012.02.005. Epub 2012 Feb 20.
2
Notch -- a goldilocks signaling pathway in disease and cancer therapy.
Discov Med. 2016 Mar;21(115):189-96.
3
CADASIL: a critical look at a Notch disease.
Dev Neurosci. 2006;28(1-2):5-12. doi: 10.1159/000090748.
4
Notch signaling and ageing.
Adv Exp Med Biol. 2015;822:25-36. doi: 10.1007/978-3-319-08927-0_6.
5
Notch signaling in normal and disease States: possible therapies related to glycosylation.
Curr Mol Med. 2007 Jun;7(4):427-45. doi: 10.2174/156652407780831593.
6
Notch signaling in human development and disease.
Semin Cell Dev Biol. 2012 Jun;23(4):450-7. doi: 10.1016/j.semcdb.2012.01.010. Epub 2012 Jan 28.
7
Notch signaling in vascular development and physiology.
Development. 2007 Aug;134(15):2709-18. doi: 10.1242/dev.004184. Epub 2007 Jul 4.
8
The role of Notch signaling pathway in metabolic bone diseases.
Biochem Pharmacol. 2023 Jan;207:115377. doi: 10.1016/j.bcp.2022.115377. Epub 2022 Dec 10.
9
Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease.
Clin Genet. 2019 Jan;95(1):85-94. doi: 10.1111/cge.13382. Epub 2018 Jun 10.
10
Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human.
EMBO Rep. 2014 Nov;15(11):1128-38. doi: 10.15252/embr.201438842. Epub 2014 Sep 24.
引用本文的文献
1
Gualou Guizhi Granule inhibits microglia-mediated neuroinflammation to protect against neuronal apoptosis and .
Front Immunol. 2025 Jan 9;15:1527986. doi: 10.3389/fimmu.2024.1527986. eCollection 2024.
2
Multiscale simulations reveal architecture of NOTCH protein and ligand specific features.
Biophys J. 2025 Jan 21;124(2):393-407. doi: 10.1016/j.bpj.2024.12.014. Epub 2024 Dec 13.
3
Renin-angiotensin system inhibitors positively impact on multiple aging regulatory pathways: Could they be used to protect against human aging?
Physiol Rep. 2024 Jun;12(12):e16094. doi: 10.14814/phy2.16094.
4
Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.
Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189140. doi: 10.1016/j.bbcan.2024.189140. Epub 2024 Jun 21.
5
Review: myogenic and muscle toxicity targets of environmental methylmercury exposure.
Arch Toxicol. 2024 Jun;98(6):1645-1658. doi: 10.1007/s00204-024-03724-3. Epub 2024 Mar 28.
6
Structural features of the Notch ankyrin domain-Deltex WWE domain heterodimer determined by NMR spectroscopy and functional implications.
Structure. 2023 May 4;31(5):584-594.e5. doi: 10.1016/j.str.2023.03.003. Epub 2023 Mar 27.
7
The Binding of CSL Proteins to Either Co-Activators or Co-Repressors Protects from Proteasomal Degradation Induced by MAPK-Dependent Phosphorylation.
Int J Mol Sci. 2022 Oct 15;23(20):12336. doi: 10.3390/ijms232012336.
8
Functional Comparison between Endogenous and Synthetic Notch Systems.
ACS Synth Biol. 2022 Oct 21;11(10):3343-3353. doi: 10.1021/acssynbio.2c00247. Epub 2022 Sep 15.
9
Functional Studies of Genetic Variants Associated with Human Diseases in Notch Signaling-Related Genes Using Drosophila.
Methods Mol Biol. 2022;2472:235-276. doi: 10.1007/978-1-0716-2201-8_19.
10
Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy.
Pharmaceuticals (Basel). 2022 Apr 29;15(5):556. doi: 10.3390/ph15050556.
本文引用的文献
1
Coordinating tissue interactions: Notch signaling in cardiac development and disease.
Dev Cell. 2012 Feb 14;22(2):244-54. doi: 10.1016/j.devcel.2012.01.014.
2
Notch signalling in smooth muscle cells during development and disease.
Cardiovasc Res. 2012 Jul 15;95(2):138-46. doi: 10.1093/cvr/cvs019. Epub 2012 Jan 19.
3
Pericytes as a new target for pathological processes in CADASIL.
Neuropathology. 2012 Oct;32(5):515-21. doi: 10.1111/j.1440-1789.2011.01290.x. Epub 2012 Jan 12.
4
Synergy between the ESCRT-III complex and Deltex defines a ligand-independent Notch signal.
J Cell Biol. 2011 Dec 12;195(6):1005-15. doi: 10.1083/jcb.201104146.
5
Renal anomalies in Alagille syndrome: a disease-defining feature.
Am J Med Genet A. 2012 Jan;158A(1):85-9. doi: 10.1002/ajmg.a.34369. Epub 2011 Nov 21.
6
Ultrastructure of granular osmiophilic material deposits (GOM) in arterioles of CADASIL patients.
Folia Neuropathol. 2011;49(3):174-80.
7
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17761-6. doi: 10.1073/pnas.1114669108. Epub 2011 Oct 17.
8
Notch3 Arg170Cys knock-in mice display pathologic and clinical features of the neurovascular disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2881-8. doi: 10.1161/ATVBAHA.111.237859. Epub 2011 Sep 22.
9
Alagille syndrome: pathogenesis, diagnosis and management.
Eur J Hum Genet. 2012 Mar;20(3):251-7. doi: 10.1038/ejhg.2011.181. Epub 2011 Sep 21.
10
Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2.
Hum Mutat. 2011 Nov;32(11):1239-42. doi: 10.1002/humu.21563. Epub 2011 Sep 12.
Zotero 插件